A detailed history of Prudential Financial Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Prudential Financial Inc holds 11,525 shares of OCUL stock, worth $114,328. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,525
Previous 11,595 0.6%
Holding current value
$114,328
Previous $79,000 26.58%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$6.45 - $9.23 $451 - $646
-70 Reduced 0.6%
11,525 $100,000
Q2 2024

Aug 13, 2024

SELL
$4.2 - $8.69 $14,322 - $29,632
-3,410 Reduced 22.73%
11,595 $79,000
Q1 2024

May 14, 2024

BUY
$3.85 - $10.93 $57,769 - $164,004
15,005 New
15,005 $136,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $764M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.